The Week in Review: May 8-12

From the relationship between social media and self-diagnosis to the FDA approval of the first treatment for agitation associated with Alzheimer disease dementia, here are highlights from the week in Psychiatric Times.

Related Keywords

United States ,Julia Adobestock ,Brexpiprazole Rexulti ,Maria Adobestock ,Johnj Miller ,Chepko Danil ,Drug Administration ,Psychiatric Times ,First Treatment ,Agitation Associated With Alzheimer Disease ,Social Media ,Partial Hospital ,Collaborative Care ,Improve Outcomes ,Patients With Schizophrenia ,Know When Referring Patients ,Ketamine Therapy ,